Ping Zhu Selected Research

Blue cone monochromatism

10/2021	Disease mechanisms of X-linked cone dystrophy caused by missense mutations in the red and green cone opsins.
1/2019	Rescue of M-cone Function in Aged Opn1mw-/- Mice, a Model for Late-Stage Blue Cone Monochromacy.
3/2018	Publisher Correction: Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy.
1/2018	Human L- and M-opsins restore M-cone function in a mouse model for human blue cone monochromacy.
1/2017	Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ping Zhu Research Topics

Disease

124	Neoplasms (Cancer) 04/2024 - 09/2000
41	Inflammation (Inflammations) 01/2024 - 05/2010
39	Rheumatoid Arthritis 01/2022 - 01/2004
32	Infections 03/2024 - 03/2006
30	Leukemia 12/2023 - 01/2003
19	Fibrosis (Cirrhosis) 12/2023 - 02/2007
18	Cardiovascular Diseases (Cardiovascular Disease) 05/2023 - 07/2012
17	Neoplasm Metastasis (Metastasis) 01/2023 - 02/2007
15	Myocardial Infarction 02/2024 - 09/2009
15	Lymphoma (Lymphomas) 02/2023 - 09/2000
15	Breast Neoplasms (Breast Cancer) 12/2022 - 12/2003
14	Hypoxia (Hypoxemia) 04/2024 - 06/2012
13	COVID-19 03/2024 - 07/2020
13	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2023 - 01/2004
13	Wounds and Injuries (Trauma) 06/2023 - 11/2009
13	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 03/2003
13	Pneumonia (Pneumonitis) 01/2022 - 03/2012
12	Insulin Resistance 04/2024 - 01/2010
12	Atherosclerosis 08/2023 - 10/2006
12	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 08/2005
11	Obesity 04/2024 - 04/2011
11	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2013
10	Hypertension (High Blood Pressure) 05/2023 - 05/2011
10	Reperfusion Injury 03/2023 - 01/2013
10	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 10/2003
10	Ankylosing Spondylitis 01/2021 - 06/2007
9	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 07/2017
9	Heart Failure 04/2024 - 05/2010
9	Thrombosis (Thrombus) 01/2024 - 04/2010
9	Pancreatitis 08/2023 - 01/2020
9	Carcinogenesis 12/2022 - 04/2012
9	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 08/2007
9	Ischemia 09/2019 - 07/2011
8	Pain (Aches) 05/2023 - 11/2009
7	Congenital Heart Defects (Congenital Heart Defect) 01/2023 - 12/2020
7	Type 2 Diabetes Mellitus (MODY) 01/2023 - 07/2009
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2022 - 12/2007
7	Arthritis (Polyarthritis) 01/2022 - 09/2014
7	Experimental Arthritis 01/2022 - 11/2006
7	Body Weight (Weight, Body) 01/2022 - 03/2006
6	Diabetes Mellitus 04/2024 - 05/2011
6	Chronic Renal Insufficiency 12/2023 - 06/2011
6	Necrosis 08/2023 - 02/2003
6	Atrophy 01/2023 - 06/2011
6	Colitis 01/2023 - 07/2012
6	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2022 - 03/2012
6	Crohn Disease (Crohn's Disease) 01/2022 - 04/2013
6	Coronary Artery Disease (Coronary Atherosclerosis) 03/2018 - 05/2011

Drug/Important Bio-Agent (IBA)

68	Proteins (Proteins, Gene)FDA Link 03/2024 - 08/2004
29	Biomarkers (Surrogate Marker)IBA 01/2024 - 05/2009
28	CytokinesIBA 01/2024 - 01/2004
23	Messenger RNA (mRNA)IBA 06/2023 - 12/2003
23	AntigensIBA 06/2023 - 02/2002
16	Peptides (Polypeptides)IBA 01/2023 - 03/2003
15	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2009
15	RNA (Ribonucleic Acid)IBA 12/2023 - 04/2002
15	AntibodiesIBA 01/2023 - 02/2002
14	EnzymesIBA 01/2024 - 02/2004
14	Therapeutic UsesIBA 12/2023 - 02/2003
14	VaccinesIBA 06/2023 - 10/2003
12	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 04/2002
12	AntioxidantsIBA 12/2023 - 07/2008
11	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2005
11	CollagenIBA 01/2022 - 01/2004
11	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 08/2003
10	AcidsIBA 08/2023 - 04/2015
10	LigandsIBA 11/2022 - 08/2004
10	MicroRNAs (MicroRNA)IBA 05/2022 - 08/2010
10	EpitopesIBA 01/2019 - 02/2002
9	Immunoglobulin G (IgG)IBA 08/2023 - 08/2004
9	HydrogelsIBA 06/2023 - 04/2014
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2022 - 05/2007
9	Monoclonal AntibodiesIBA 01/2021 - 12/2003
8	Triglycerides (Triacylglycerol)IBA 04/2024 - 01/2010
8	CreatinineIBA 12/2023 - 05/2011
8	AlbuminsIBA 12/2023 - 06/2015
8	LipopolysaccharidesIBA 11/2022 - 04/2009
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 05/2010
8	Retinaldehyde (Retinal)IBA 09/2019 - 01/2014
7	GlucocorticoidsIBA 01/2023 - 04/2012
7	Oxygen (Dioxygen)IBA 01/2023 - 12/2016
7	Transcription Factors (Transcription Factor)IBA 12/2022 - 06/2012
6	LipidsIBA 04/2024 - 01/2010
6	CateninsIBA 03/2024 - 12/2014
6	Long Noncoding RNAIBA 03/2024 - 01/2019
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 01/2013
6	CholesterolIBA 01/2024 - 01/2010
6	Small Interfering RNA (siRNA)IBA 02/2023 - 07/2012
6	AutoantibodiesIBA 01/2023 - 01/2009
6	Bleomycin (Blenoxane)FDA LinkGeneric 11/2022 - 03/2012
6	Infliximab (Remicade)FDA Link 01/2022 - 07/2009
6	Glycoproteins (Glycoprotein)IBA 01/2021 - 10/2003
6	Interleukin-6 (Interleukin 6)IBA 05/2020 - 05/2010
6	Saline SolutionIBA 01/2018 - 11/2008

Therapy/Procedure

71	Therapeutics 01/2024 - 07/2003
18	Drug Therapy (Chemotherapy) 01/2023 - 01/2003
16	Immunotherapy 06/2023 - 08/2005
15	Hematopoietic Stem Cell Transplantation 12/2023 - 10/2003
9	Transplantation 01/2023 - 09/2012
7	Injections 07/2022 - 08/2004